ArrePath

Deciphering biology, discovering new classes of anti-infectives

Princeton, United States · Founded 2021 · $21.3M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$21.3M
Last Round
$1.3M Series AJun 2025
Rounds
3

About

ArrePath is a Princeton-based biotech company applying AI, machine learning, and advanced imaging technologies to discover new classes of small molecule anti-infectives targeting antimicrobial resistance. The company was spun out of Princeton University's Gitai Lab and has developed early proof-of-concept antibiotics now advancing toward clinical development.

Summary

ArrePath is a Life Sciences company based in Princeton, United States, founded in 2021. It has raised $21.3M in total across 3 rounds, most recently a $1.3M Series A round in Jun 2025. Investors include Boehringer Ingelheim Venture Fund, Pace Ventures and Insight Partners.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2025

Sign up to see all 3 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ArrePath on Indexed.vc
<a href="https://indexed.vc/companies/arrepath"><img src="https://indexed.vc/api/badge/company/arrepath" alt="ArrePath on Indexed.vc" width="260" height="76" /></a>